GlaxoSmithKline Innoviva\'s Trelegy Ellipta improves lung function in latestage study of patients with uncontrolled asthma httpbit.ly2ZNyGcx $GSK pharma

GlaxoSmithKline, Innoviva's Trelegy Ellipta improves lung function in late-stage study of patients with uncontrolled asthma http://bit.ly/2ZNyGcx  $GSK #pharma

16:55 EDT 2 May 2019 | FirstWord Pharma

GlaxoSmithKline, Innoviva's Trelegy Ellipta improves lung function in late-stage study of patients with uncontrolled asthma http://bit.ly/2ZNyGcx  $GSK #pharma

More From BioPortfolio on "GlaxoSmithKline, Innoviva's Trelegy Ellipta improves lung function in late-stage study of patients with uncontrolled asthma http://bit.ly/2ZNyGcx  $GSK #pharma"